FDA Advisory Committee Recommends Approval of Endari™ from Emmaus Life Sciences for the Treatment of Sickle Cell DiseaseMay 24, 2017 Read More
Emmaus Life Sciences Inc. Announces FDA Advisory Committee Meeting for Endari™ for Sickle Cell DiseaseApril 18, 2017 Read More
Emmaus Life Sciences, Inc. Receives Notice of Allowance for U.S. Patent for use of L-glutamine in Treatment of Diverticulosis February 01, 2017 Read More
Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology CorporationJanuary 25, 2017 Read More
Emmaus Life Sciences, Inc. Receives Japanese Patent for use of L-glutamine in Treatment of DiverticulosisDecember 13, 2016 Read More
